Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2
Data_Sheet_1_Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2.pdf
Arold, Stefan T.
Duarte, Carlos M.
KAUST DepartmentBiological and Environmental Sciences and Engineering (BESE) Division
Computational Bioscience Research Center (CBRC)
Computer Science Program
Computer, Electrical and Mathematical Sciences and Engineering (CEMSE) Division
Marine Science Program
Pathogen Genomics Laboratory
Red Sea Research Center (RSRC)
Structural Biology and Engineering
KAUST Grant NumberFCC/1/1976-25-01
Preprint Posting Date2020-03-06
Permanent link to this recordhttp://hdl.handle.net/10754/661831
MetadataShow full item record
AbstractThe spread of the novel coronavirus (SARS-CoV-2) has triggered a global emergency, that demands urgent solutions for detection and therapy to prevent escalating health, social, and economic impacts. The spike protein (S) of this virus enables binding to the human receptor ACE2, and hence presents a prime target for vaccines preventing viral entry into host cells. The S proteins from SARS and SARS-CoV-2 are similar, but structural differences in the receptor binding domain (RBD) preclude the use of SARS-specific neutralizing antibodies to inhibit SARS-CoV-2. Here we used comparative pangenomic analysis of all sequenced reference Betacoronaviruses, complemented with functional and structural analyses. This analysis reveals that, among all core gene clusters present in these viruses, the envelope protein E shows a variant cluster shared by SARS and SARS-CoV-2 with two completely-conserved key functional features, namely an ion-channel, and a PDZ-binding motif (PBM). These features play a key role in the activation of the inflammasome causing the acute respiratory distress syndrome, the leading cause of death in SARS and SARS-CoV-2 infections. Together with functional pangenomic analysis, mutation tracking, and previous evidence, on E protein as a determinant of pathogenicity in SARS, we suggest E protein as an alternative therapeutic target to be considered for further studies to reduce complications of SARS-CoV-2 infections in COVID-19.
CitationAlam, I., Kamau, A. K., Kulmanov, M., Arold, S. T., Pain, A. T., Gojobori, T., & Duarte, C. M. (2020). Functional pangenome analysis points to protein E, a pathogenicity determinant in SARS, as a therapeutic target for COVID-19 complications. doi:10.3389/fcimb.2020.00405
SponsorsThe research reported in this publication was supported by funding from King Abdullah University of Science and Technology (KAUST), under award number FCC/1/1976-25-01.
We are thankful to KAUST Supercomputing Laboratory (KSL), KAUST Information Technology (IT) and Muhammad Saif from CBRC, KAUST for providing support in computing resources. We are grateful to all the authors and GSAID for providing access to SARS-CoV-2 isolates for research, contributing labs and authors are clearly shown in the metadata table at https://trackncov.cbrc.kaust.edu.sa.
PublisherFrontiers Media SA
RelationsIs Supplemented By:
Betacoronavirus PanGenome DB. URL: https://pangenomedb.cbrc.kaust.edu.sa/
CollectionsArticles; Biological and Environmental Science and Engineering (BESE) Division; Red Sea Research Center (RSRC); Bioscience Program; Marine Science Program; Computer Science Program; Computational Bioscience Research Center (CBRC); Computer, Electrical and Mathematical Science and Engineering (CEMSE) Division
Except where otherwise noted, this item's license is described as © 2020 Alam, Kamau, Kulmanov, Jaremko, Arold, Pain, Gojobori and Duarte. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.